Enhanced Pharmaceuticals GHK CU
(Inclusive of All Taxes)
Original price was: ₹13,499.00.₹6,000.00Current price is: ₹6,000.00.
- 10% Advance 90% Cash on Delivery
- 100% Purchase Safety | Secure Payments
- Sold & Fulfilled by ncrfoodsupplements.com - Brand Authorized
- Super Fast Delivery Average time: 1 to 3 days for Delhi-NCR 3 to 5 for rest of India - Free Delivery
- Fssai Lic No. 23322010002144
- Genuine Product All our products are far from expiry, and procured directly from the brand or authorized importers of brand
- Return Policy All return requests are subject to an unboxing video only. You must have unboxing video of product.
Description
Enhanced Pharmaceuticals GHK-Cu 50 mg is a high-purity copper peptide complex formulated for advanced research and laboratory applications. GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring tripeptide that binds copper ions and plays a role in multiple cellular signalling pathways.
This product is supplied as a 50 mg lyophilised GHK-CU, accompanied by bacteriostatic for reconstitution, ensuring precision, stability, and ease of preparation.
Product Details
Peptide: GHK-Cu (Copper Peptide)
Strength: 50 mg per vial
Form: Lyophilised (freeze-dried) powder
Includes: One 50 mg GHK-Cu
About GHK-Cu
Pioneers of Human Evolution
GHK-Cu is widely studied in cellular and regenerative research due to its involvement in:
Cellular repair and signalling pathways
Tissue remodelling and extracellular matrix activity
Skin, hair, and connective tissue research models
Anti-oxidative and anti-inflammatory mechanisms (research context)
Naturally present in human plasma, saliva, and urine, GHK-Cu has become a compound of interest in research related to longevity, dermatology, and regenerative medicine.
Quality & Manufacturing
Produced under GMP-aligned manufacturing standards
Each batch undergoes quality and purity verification
Clearly labelled with lot number and use-by date
* Designed for accuracy, consistency, and research reliability
Reviews
Clear filtersThere are no reviews yet.